scholarly journals First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

2014 ◽  
Vol 21 (3) ◽  
pp. 553-560 ◽  
Author(s):  
Jordi Rodon ◽  
Michael A. Carducci ◽  
Juan M Sepulveda-Sánchez ◽  
Analia Azaro ◽  
Emiliano Calvo ◽  
...  
Keyword(s):  
Growth Factor ◽  
Advanced Cancer ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
Transforming Growth Factor Β ◽  
The Novel ◽  
Human Dose ◽  
Dose Study ◽  
Β Receptor

scholarly journals Case Series of Cancer Patients Treated With Galunisertib, a Transforming Growth Factor-Beta Receptor I Kinase Inhibitor in a First-in-Human Dose Study

2014 ◽  
Vol 5 (11) ◽  
pp. 603-609
Author(s):  
Analia Azaro ◽  
Jordi Rodon ◽  
Michael Carducci ◽  
Juan M. Sepulveda-Sanchez ◽  
Ivelina Gueorguieva ◽  
...  
Keyword(s):  
Growth Factor ◽  
Cancer Patients ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
Case Series ◽  
Beta Receptor ◽  
Human Dose ◽  
Dose Study ◽  
Growth Factor Beta

P48. Transforming growth factor β receptor I kinase inhibitor and bisphosphonates are additive to reduce breast cancer bone metastases

2008 ◽  
Vol 34 ◽  
pp. 37-38 ◽  
Author(s):  
Khalid Mohammad ◽  
Elizabeth Stebbins ◽  
Lauren Kingsley ◽  
Pierrick Fournier ◽  
Maria Niewolna ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Growth Factor ◽  
Bone Metastases ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
Transforming Growth Factor Β ◽  
Β Receptor
Sign in / Sign up

Export Citation Format

Share Document